3004 90 92 70

Code

3004 90 92 70

Type

10-digit tariff line

Duty rate

Free (set at subheading 30049092)

Unit

kg

Classification rulings (U.S. Customs, CROSS)

• N351520 · 2025-08-18 — The tariff classification of Ferric Citrate Tablets and Bosentan Tablets for Oral Suspension in dosage form from India

  Ferric Citrate, imported in 210 mg tablets, is in a class of medications called phosphate binders. It is indicated for the treatment of hyperphosphatemia (elevated level of phosphate in the blood) in patients with chronic kidney disease (CKD) who are on dialysis. Ferric Citrate is also used to treat iron deficiency anemia in patients with CKD who are not on dialysis. Bosentan for oral suspension, imported in 32 mg tablets, is a dual endothelin receptor antagonist. It is indicated for the treatment of pulmonary arterial hypertension (PAH) in adults to improve exercise ability and decrease…

• N348833 · 2025-06-06 — The tariff classification of Potassium Chloride Powder for Oral Solution in dosage form, from the United States

  Potassium Chloride Powder, imported in 20 mEq for Oral Solution, is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis. In your letter, you stated the country of origin will be the United States and exported from India. The applicable subheading for the Potassium Chloride Powder for Oral Solution in dosage form will be 3004.90.9270, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings…

• N347734 · 2025-05-08 — The tariff classification of Peritoneal Dialysis (PD) solutions of Extraneal® (icodextrin) and Dianeal® (dextrose), in dosage form, from Mexico

  We note that the request did not seek a determination as to country of origin, or as to the applicability of preferential treatment under the U.S.-Mexico-Canada Agreement; as such, this ruling does not address those issues. The Peritoneal Dialysis (PD) solutions imported in ultrabags are used to remove excess fluid, correct electrolyte problems, and remove toxins in those with kidney failure. Extraneal (icodextrin) is indicated for the management of kidney failure in patients requiring long-term kidney replacement therapy. Dianeal (dextrose) is indicated for the management of acute or chronic…

• N343512 · 2024-11-13 — The tariff classification of Sevelamer Hydrochloride Tablets in dosage form, from India

  Sevelamer Hydrochloride, imported in 800 mg tablets, is a phosphate binder used to treat hyperphosphatemia, an electrolyte disorder in which there is an elevated level of phosphate in the blood. It is also used to control phosphorus levels in patients with chronic kidney disease who are on dialysis. The applicable subheading for the Sevelamer Hydrochloride Tablets in dosage form will be 3004.90.9270, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses ……

• N342773 · 2024-10-10 — The tariff classification of Sevelamer Carbonate Powder in dosage form, from Taiwan

  Sevelamer Carbonate Powder, imported in retail packages of 0.8 grams, is a phosphate binder that is available by prescription only. It is indicated for the control of serum phosphorus in patients with Chronic Kidney Disease (CDK) on hemodialysis. In your letter, you stated the Sevelamer Carbonate Powder is exported from India and the country of origin is Taiwan. The applicable subheading for the Sevelamer Carbonate Podwer in dosage form will be 3004.90.9270, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments…consisting of mixed or unmixed products for…

• 3004 90 92 49 — Other: — Medicaments primarily affecting the central nervous system: — Other: — Other
• 3004 90 92 50 — Other: — Dermatological agents and local anesthetics: — Containing lidocaine or its salts
• 3004 90 92 51 — Other: — Dermatological agents and local anesthetics: — Other
• 3004 90 92 52 — Other: — Medicaments primarily affecting the digestive system: — Laxatives
• 3004 90 92 53 — Other: — Medicaments primarily affecting the digestive system: — Antacids
• 3004 90 92 54 — Other: — Medicaments primarily affecting the digestive system: — Containing famotidine or its salts
• 3004 90 92 55 — Other: — Medicaments primarily affecting the digestive system: — Containing pantoprazole or its salts
• 3004 90 92 56 — Other: — Medicaments primarily affecting the digestive system: — Containing ondansetron or its salts
• 3004 90 92 57 — Other: — Medicaments primarily affecting the digestive system: — Containing glycopyrrolate or its salts
• 3004 90 92 58 — Other: — Medicaments primarily affecting the digestive system: — Containing loperamide or its salts
• 3004 90 92 60 — Other: — Medicaments primarily affecting the digestive system: — Other
• 3004 90 92 61 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Diuretics: — Containing furosemide and its salts
• 3004 90 92 62 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Diuretics: — Containing hydrochlorothiazide or its salts
• 3004 90 92 63 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Diuretics: — Other
• 3004 90 92 64 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Containing calcium gluconate
• 3004 90 92 65 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Containing potassium chloride
• 3004 90 92 66 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Containing sodium bicarbonate, in injection form
• 3004 90 92 67 — Other: — Preparations primarily affecting the electrolytic, caloric or water balance: — Other: — Other
• 3004 90 92 68 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Cough and cold preparations
• 3004 90 92 69 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Antihistamines: — Containing diphenhydramine or its salts
• 3004 90 92 71 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Containing albuterol sulfate
• 3004 90 92 72 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Other: — Containing timolol maleate
• 3004 90 92 73 — Other: — Medicaments primarily affecting the eyes, ears, or respiratory system: — Other: — Other: — Other
• 3004 90 92 74 — Other: — Other: — Containing heparin sodium or its salts
• 3004 90 92 75 — Other: — Other: — Containing zoledronic acid or its salts
• 3004 90 92 76 — Other: — Other: — Other

• 30049 — ТН ВЭД ЕАЭС: прочие:
• 300490 — EU CN/TARIC: Other

Related news

• FMC proposes $200,000 fee on Spanish-flag ships and curbs on Spanish imports
• BIS details zero-tariff drug categories ahead of September 29 tariff

Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.